PolarityTE, Inc. (PTE)
Class Action & Lead Plaintiff Deadline: November 23, 2021
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against PolarityTE, Inc. (“PolarityTE” or the “Company”) (NASDAQ: PTE) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired PolarityTE securities between April 30, 2020 and August 23, 2021, inclusive (the “Class Period”).
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts and failed to disclose to investors that: (1) the SkinTE IND was deficient with respect to certain Chemistry, Manufacturing, and Control items; (2) as a result, it was unlikely that the FDA would approve the SkinTE IND in its current form; (3) accordingly, the Company had materially overstated the likelihood that the SkinTE IND would obtain FDA approval; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.
A class action lawsuit has already been filed. You can review a copy of the Complaint and sign the certifiaction form or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in PolarityTE you have until November 23, 2021, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.